Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Notes Payables (2019 - 2025)

Volitionrx's Notes Payables history spans 4 years, with the latest figure at $2.4 million for Q4 2025.

  • For Q4 2025, Notes Payables changed N/A year-over-year to $2.4 million; the TTM value through Dec 2025 reached $2.4 million, changed N/A, while the annual FY2025 figure was $2.4 million, N/A changed from the prior year.
  • Notes Payables reached $2.4 million in Q4 2025 per VNRX's latest filing, up from $1.5 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $2.4 million in Q4 2025 to a low of $166522.0 in Q2 2025.